Revolax

Revolax is a brand of dermal fillers developed by the South Korean company Across Co., Ltd. Introduced in the UK in 2017, the brand is recognized for its high-quality formulations featuring cross-linked hyaluronic acid derived from non-animal sources, ensuring safe, effective, and biocompatible results with no traces of BDDE residue. The Revolax fillers are categorized by viscosity and injection depth: Revolax Fine for superficial lines, Revolax Deep for deeper wrinkles and facial augmentation, and Revolax Sub-Q for contouring and volumization. Most products contain 0.3% lidocaine to minimize discomfort during treatment and improve patient comfort. Certified as CE Class III, Revolax follows the strict safety and quality standards of the UK and EU, offering a low migration risk and long-lasting, natural-looking results.